UK Startup Funding Report: £1314.6m raised across Fintech, Biotech and Hardware (9–13 Nov 2026).
It's Friday, 13 November, and this is your UK Startup Funding Report.
A busy week for UK startups saw a string of big rounds across fintech, biotech and hardware, with investors ploughing capital into both deeptech and regulated finance plays. High-profile growth rounds and strategic public backing pushed total disclosed funding to £1314.6M for 9–13 Nov 2026.
AI and compute infrastructure
Investors are increasingly directing large cheques towards the hardware and systems that underpin generative AI, signalling a shift from pure model bets to the stacks that run them more cheaply and at scale. Interest this week focused on chipmakers, parallel architectures and creative toolchains that address memory bandwidth, inference costs and new media formats.
Among the notable rounds, Fractile raised £540 million in a Series C led by Thrive and Founders Fund to scale vertically integrated AI inference hardware and expand manufacturing in London and Bristol. Tendrils secured about £22.43 million in a growth round led by Benchmark to pursue a parallel‑first processor architecture and to develop the open‑source Vine language for many‑core designs. Anorak took £4 million in a seed round co‑‑led by Play Ventures and Backed VC to build interactive generative video tools and a creator platform for playable, responsive content, with strategic backing from Supercell and MTG.
Taken together, the financings show investor conviction that hardware, runtimes and creative toolchains will materially shape AI economics and developer workflows. How these firms sequence product rollouts remains to be seen, but the pattern makes clear that both foundational compute and novel media form factors are now in vogue with strategic and financial backers.
This week's AI & Compute deals:
Fractile raised £540m in a Series C led by Thrive and Founders Fund to scale its vertically integrated AI inference hardware and expand manufacturing from London and Bristol. The funding underlines investor appetite for hardware-first approaches to tackle memory-bandwidth limits in model inference and to build UK capability in AI chips. Investors include Lightspeed, Redpoint, Balderton and UK public funds.
Tendrils raised £22.4m in a growth round led by Benchmark to pursue a parallel‑first processor architecture and an accompanying open‑source language, Vine. The capital will fund hardware and software co‑design as the company challenges legacy CPU models with many‑core designs aimed at parallel workloads. Investors include Visionaries Club and the UK Sovereign AI Fund.
Anorak raised £4m in a seed round co‑led by Play Ventures and Backed VC to build interactive generative video and a creator platform for playable, responsive content. The cash will help turn experiments into a toolkit for niche communities and creators, with strategic backing from Supercell and MTG. The team is split between London and Chengdu for creative and AI engineering capability.
Regulated fintech and embedded finance
Capital continues to flow to regulated infrastructure and applied AI that can be embedded into existing financial platforms. This week’s activity emphasised embedded banking services, accounting automation and real‑time decisioning — capabilities that scale across regulated footprints and can be integrated into incumbent rails.
Griffin closed about £75.24 million in growth capital led by Octagon Partners to add card issuing and stablecoin services to its agentic banking platform and broaden its embedded stack for more than 80 customers. Sumary raised £19 million to accelerate European expansion, make London its commercial hub and scale a Copenhagen AI research team focused on accounting automation. Ancep secured about £6.33 million in a round led by Creandum to deploy AI agents that automate routine commercial insurance placement tasks. Planky closed roughly £5.76 million to pivot towards a real‑time AI decisioning layer for banks, lenders and embedded finance platforms, leveraging the regulated footprint of its parent group.
Taken together, the rounds point to a clear investor preference for companies that marry compliance with programmability rather than stand‑alone consumer propositions. Which firms ultimately win at scale will depend on execution and partnerships, but the pattern of infrastructure‑first funding is unmistakable.
This week's Fintech & Insurtech deals:
Griffin closed about £75.2m in growth capital led by Octagon Partners to add card issuing and stablecoin services to its agentic banking platform. The funding will help the company broaden its embedded banking stack for the 80+ customers that already run on its infrastructure while navigating added regulatory complexity. Notion Capital and other fintech investors joined the round.
Sumary raised £19m to accelerate its European expansion, establish London as its commercial hub and scale its Copenhagen AI research team for accounting automation. The startup offers an AI operating system that automates core accounting workflows, and the funding will support go‑to‑market growth across the UK, Benelux and wider Europe. Investors include Singular, Partech and byFounders.
Ancep raised £6.3m to speed deployment of its AI agents that automate routine commercial insurance placement tasks for brokers. The capital will accelerate hiring and rollouts aimed at recovering low-margin risks and creating net new revenue for brokerages. The round was led by Creandum with participation from Kleiner Perkins.
Planky closed roughly £5.8m (€6.9m) to pivot from Open Banking analytics to a real‑time AI decisioning layer for banks, lenders and embedded finance platforms. The funding will help build continuous credit reads and monitoring products across EMEA and MENA, leveraging the regulated footprint of its parent group. Innovation Global and Azimut-backed funds led the round.
Translational biotech and platform science
Investors are favouring platform science and translational approaches that can be de‑risked on a path to the clinic. This week’s financings covered CNS targeted degradation, human cell models, engineered microbes and translational in vivo platforms — a spread that reflects demand for reproducible biology and novel therapeutic modalities.
Oyster Therapeutics raised about £44.68 million in a Series A led by 4BIO Capital with strategic participation from Eli Lilly to advance oral, brain‑penetrant targeted protein degraders for tau‑driven neurodegenerative disease and to progress its SELFTAC platform towards clinical trials. bio.bit secured £18.57 million in a Series C to scale production of human cell models and widen commercial access to its ioCells portfolio for pharma and academia. Neobe took in about £5.06 million in seed funding to develop engineered bacteria intended to break down dense tumour matrices ahead of an IND filing. PhaSER Biomedical obtained a £2 million grant renewal from the Bill & Melinda Gates Foundation to continue providing humanised 8HUM mouse models for neglected disease drug discovery.
These rounds reveal an investor tilt towards companies that bridge discovery and development, where better models or novel modalities can shorten timelines to patients. Strategic pharmaceutical participation and the clustering of deals around established UK life‑science hubs underline the translational intent of many of the financings.
This week's Biotech & Healthtech deals:
Oyster Therapeutics raised £44.7m in a Series A led by 4BIO Capital with strategic participation from Eli Lilly to advance oral, brain‑penetrant targeted protein degraders for tau-driven neurodegenerative diseases. The funding is aimed at progressing its SELFTAC platform towards clinical trials and reflects growing investor interest in CNS‑directed degradation approaches. Existing life‑science backers also joined the round to support translational work.
bit.bio (branded here as bio.bit) secured £18.6m in a Series C to scale production and widen commercial access to its human cell models used in drug discovery and testing. The funding will expand the ioCells portfolio and manufacturing capacity to meet growing demand from pharma and academia for reproducible human biology. Backers include M&G Investments and angel investor Dr Jonathan Milner.
Neobe raised £5.1m in seed funding to advance engineered bacteria that break down dense tumour matrices and improve drug and immune cell access to solid tumours. The round will fund preclinical work on lead programme NEO22 and preparations for an IND filing targeted for 2028. Investors include ARC Ventures and Macmillan Ventures.
PhaSER Biomedical secured a £2m grant renewal from the Bill & Melinda Gates Foundation to continue providing humanised 8HUM mouse models for neglected disease drug discovery. The two‑year award funds wider access to translational models and computational tools that can improve preclinical predictivity for diseases with limited commercial investment. The grant supports collaborative research and regulatory engagement to accelerate candidate selection.
Defence, space and sensing scale‑up
Large defence and security rounds this week paired private capital with sovereign support to industrialise autonomous platforms and sensing infrastructure. Funders are backing production of combat‑proven systems, MEMS sensors for GPS‑limited navigation, and data platforms that create common spatial references from seabed to orbit.
UFORCE closed about £530 million in growth funding co‑led by Valor Equity Partners and the UK National Wealth Fund to scale production of uncrewed sea, land and air platforms and expand global manufacturing while preserving Ukrainian industrial capability. Silicon Microgravity raised £6 million in a round led by West Hill Capital to scale UK manufacturing of MEMS inertial and gravity sensors for navigation and subsurface imaging. MISTT secured £5 million in growth capital led by Expeditions to build a four‑dimensional spatial‑temporal reference platform, prioritising defence customers and UK government pilots. Crowd Threat took in about £1 million from Mercia Ventures and PXN Ventures to expand its crowdsourced threat intelligence network.
The financings underscore a recurring pattern: strategic objectives and commercial deployment are closely intertwined. Expect more rounds that combine sovereign support and specialist investors as governments and defence customers seek resilient, fieldable systems at scale.
This week's Defence, Space & Security (and Deeptech Sensors) deals:
UFORCE closed a £530m growth round co-led by Valor Equity Partners and the UK National Wealth Fund to scale production of uncrewed sea, land and air platforms and expand manufacturing globally. The deal pairs private capital with sovereign support and aims to preserve Ukrainian industrial capability while industrialising combat‑proven autonomous systems. The round attracted a mix of strategic and financial investors including Menlo Ventures and Hiro Capital.
Silicon Microgravity raised £6m to scale UK manufacturing of MEMS inertial and gravity sensors for GPS‑limited navigation, defence, space and subsurface imaging markets. The funding will support commercial deployments and help the company convert technical progress into fielded systems. The round was led by West Hill Capital with participation from UKI2S and Oxford Innovation Finance.
MISTT raised £5m to develop a four‑dimensional spatial‑temporal reference platform that gives AI models and autonomous systems a common, uncertainty‑aware record of events from seabed to orbit. The company is prioritising defence customers and UK government pilots while pitching civil use cases such as shipping and climate monitoring. The round was led by Expeditions with Seedcamp and NSSIF among the backers.
Crowd Threat raised £1m from Mercia Ventures and PXN Ventures to expand its crowdsourced threat intelligence network and develop global coverage. The platform pays local contributors for incident reports and combines human verification with AI to speed actionable reporting for governments and security teams. The funding will be used to grow the contributor base and product capabilities.
Greentech, mobility and niche consumer plays
This week’s mixed set of financings stretched across greentech, mobility, food, education and niche media, illustrating investor interest in both deep R&D and mission‑driven consumer brands. Deals ranged from development‑stage robotics programmes to small pre‑seed rounds for specialist food and education platforms, underscoring that sector‑specific solutions continue to attract targeted capital.
Atmospheric AI raised about £7 million in seed funding led by DBL Partners to scale computational models of industrial raw material production and extend coverage beyond plastics into chemicals, paper and metals. PORT secured roughly £12.1 million in a round led by EBRD to develop AI‑powered autonomous delivery robots, training navigation systems from real courier journeys in its microhub network. GraphEnergyTech closed a seed tranche with follow‑on support from Aramco Ventures to scale metal‑free carbon and graphene electrode technology for solar and energy applications. Pro Climbing League took £3 million to internationalise its professional climbing events and media platform, while JADE and The Insect Café raised smaller rounds to scale an agent management platform and cricket protein production respectively.
These transactions reflect a pragmatic appetite for targeted investment: corporate and strategic backers appear across the set, signalling that partnerships and pilots will be important routes to commercial traction for both deep technology and consumer‑facing operators.
This week's Other: Greentech, Mobility, Food, Edtech & Media deals:
Atmospheric AI raised £7m in seed funding to scale computational models of industrial raw‑material production for manufacturers' sourcing teams. The money will extend coverage beyond plastics into chemicals, paper and metals and support commercial roll‑out to customers seeking cost, carbon and resilience visibility. The round was led by DBL Partners with participation from RAISE and others.
PORT raised about £12.1m (€14.5m) to develop AI‑powered autonomous delivery robots using data gathered from its courier network and microhubs. The funding will support a development‑stage robotics programme that trains navigation systems from real delivery journeys rather than immediate robot roll‑out. The round was led by EBRD and Balnord.
GraphEnergyTech closed the first tranche of a seed round bringing follow‑on support from Aramco Ventures to scale metal‑free carbon and graphene electrode technology for solar and energy applications. The financing will fund industrial validation and partner pilots as the company seeks to replace precious metal electrodes with printed conductive inks. The round signals corporate interest in materials innovation for resilient energy supply chains.
Pro Climbing League raised £3m to internationalise its city‑based professional climbing events and media platform and deliver a full season from 2027. The funding will support commercial and content operations, international expansion and larger prize pools to professionalise the sport. Redrice Ventures led the seed round with Active Partners and others.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.